Naptumomab is a tumor targeting immunotherapy that has been developed for the treatment of solid tumors. Naptumomab functions by activating T cells and re-direct them to 5T4-expressing tumors.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.